3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
13
Leukemia, Myeloid, Acute
13
Leukemia
5
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Leukemia, Myelomonocytic, Chronic
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Anemia, Refractory, with Excess of Blasts
3
Primary Myelofibrosis
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Hodgkin Disease
2
Blast Crisis
2
Thrombocytosis
1
Small Cell Lung Carcinoma
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
fludarabine phosphate
34
Cyclophosphamide
31
Peripheral Blood Stem Cell Transplantation
27
Mycophenolic Acid
25
Cyclosporine
23
Antilymphocyte Serum
23
Busulfan
20
Tacrolimus
17
Radiotherapy
17
Filgrastim
17
Whole-Body Irradiation
15
Methotrexate
15
Methylprednisolone
14
Melphalan
13
Cord Blood Stem Cell Transplantation
12
venetoclax
9
Cytarabine
8
Azacitidine
8
fludarabine
5
Etoposide
5
sargramostim
4
Therapeutics
4
Sirolimus
4
Decitabine
4
Clofarabine
4
Alemtuzumab
4
thymoglobulin
3
nilotinib
3
merphos
2
Voriconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Tretinoin
×
Myeloid
×
Clear all
NCT02717884
2018-10-18
TRANSATRA
University Hospital Freiburg
Phase 1/2
Unknown
60 enrolled